Finland · Delayed Price · Currency is EUR Herantis Pharma Oyj Statistics
Total Valuation
HEL:HRTIS has a market cap or net worth of EUR 42.94 million. The enterprise value is 39.45 million.
| Market Cap | 42.94M |
| Enterprise Value | 39.45M |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HEL:HRTIS has 26.50 million shares outstanding. The number of shares has increased by 12.25% in one year.
| Current Share Class | 26.50M |
| Shares Outstanding | 26.50M |
| Shares Change (YoY) | +12.25% |
| Shares Change (QoQ) | +14.37% |
| Owned by Insiders (%) | 14.44% |
| Owned by Institutions (%) | 39.40% |
| Float | 15.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -53.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89
| Current Ratio | 2.89 |
| Quick Ratio | 2.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,415.14% and return on invested capital (ROIC) is -814.59%.
| Return on Equity (ROE) | -1,415.14% |
| Return on Assets (ROA) | -88.85% |
| Return on Invested Capital (ROIC) | -814.59% |
| Return on Capital Employed (ROCE) | -246.16% |
| Weighted Average Cost of Capital (WACC) | 7.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -481,653 |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.34% in the last 52 weeks. The beta is 0.60, so HEL:HRTIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -2.34% |
| 50-Day Moving Average | 1.70 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 50.96 |
| Average Volume (20 Days) | 38,984 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.50M |
| Pretax Income | -6.74M |
| Net Income | -6.74M |
| EBITDA | n/a |
| EBIT | -6.50M |
| Earnings Per Share (EPS) | -0.27 |
Balance Sheet
The company has 3.51 million in cash and 20,000 in debt, with a net cash position of 3.49 million or 0.13 per share.
| Cash & Cash Equivalents | 3.51M |
| Total Debt | 20,000 |
| Net Cash | 3.49M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | -796,000 |
| Book Value Per Share | -0.03 |
| Working Capital | 2.64M |
Cash Flow
| Operating Cash Flow | -6.04M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 701,595 |
| Free Cash Flow | -6.04M |
| FCF Per Share | -0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEL:HRTIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.25% |
| Shareholder Yield | -12.25% |
| Earnings Yield | -15.71% |
| FCF Yield | -14.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |